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Polyelonal ntibodies have been raised against wo synthetic peptide5 reproducing the 48-64 and 353-369 scqaen~s ofCSK, a protein tyrosine 
kinase implicated inthe down-regulation of sre-related protein kinases. Both antibodies specifically recognize r combinant CSK and a CSK-related 
49 kDa protein tyrosine kinase pr~ent in spleen but they do not cross-react with purified TPK-nB, a spleen protein tyro~ine kina~ sharing with 
CSK catalytic activity toward src kina~es and incapability oautophosphorylate. CSK and TPK-IIB once resolved from each other by heparin- 
5epharose affinity chromatography, display opposite specifieities toward synthetic ~ptides reproducing tile sequences around the main phosphoae- 
ceptor esidues of pp60 ''~'~, namely Tyr-416 and Tyr-527. The~ data support the view that TPK-IIB and CSK may exert opposite ff~ts on the 
activity of src-related protein tyrosine kinases. 
Protein tyrosine kinase; pp60 '''~ regulation; Phosphot2crosine; Peptide; Spleen 
1, INTRODUCTION 
A common feature of most protein tyrosine kinanes 
is their capability to autophosphorylate [1,2], Such an 
autophosphorylation primarily occurs at a site which is 
homologous to the main autophosphorylation site of  
pp60 ~''~, i.e. Tyr-416, and correlates with an activation 
of the kinase [1,3]. A notable exception is provided by 
a protein tyrosine kinase initially isolated from brain 
[4,5] and subsequently found in a variety of tissues in- 
eluding spleen and lymphoid cells [5,6] which is devoid 
of  any evident autophosphorylation activity and has 
been termed CSK (c.src kinase) after its capability to 
phosphorylate c-src at its C-terminal, down-regulating 
site, i.e. Tyr-527 [5]. CSK can also phosphorylate and 
inactivate the src family kinases p56/yn, p59fyn [6] and 
p56t'ck [7]. The deduced amino acid sequence of CSK 
revealed a certain extent of homology with other known 
tyrosine protein kinases, but it lacks any potential 
phosphoacceptor site in the region homologous to that 
harbouring Tyr-416 in pp60 *'''~ [5]. 
The unusual property of lacking autophosphoryla- 
tion activity is shared by a tyrosine kinase isolated from 
spleen and conventionally termed TPK-I IB [8]. TPK- 
l iB proved immunologieally unrelated to the src family, 
while capable to phosphorylate in vitro the src-related 
lyn product [9], To check the possible relation between 
TPK-1IB and CSK we have now raised antibodies 
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against wo CSK synthetic peptides, Here we show that 
these antisera do not cross-react with purified TPK-11B, 
while they readily recognize a spleen 49 kDa protein 
tyrosine kiaase the activity ratio of which toward syn- 
thetic peptides reproducing the two main phosphoac- 
ceptor sites of pp60 ~'~ (Tyr-416 and Tyr-527) is oppo- 
site to that exhibited by TPK-11B. 
2. MATERIALS AND METHODS 
Angiotensin l wa~ purchased from Sigma. The peptide EDNEYTA 
was synthesized bya manual .~ynthe~izer (Model Biolinx 4175, LKB) 
using the continuou~ flow variant of the 'Fmo¢-polyamide' m thod on 
the Kieselguhr-supported polydimethylacrylamide resin functional- 
ized with 4.hydroxymethylphenoxy-a~tic cid (NovaSynR KA- 
Novabioehem AG) [9]. Other peptides were synthesized byan auto- 
mated synthesizer from Applied Biosystems (Model 431-A), using 
Fmoe/N MP (N-methylpyrrol-;done) ch mistry on hydroxymethylphe- 
noxymethyl-resin (HMP-Applied Biosystems). 
2.1. Antibod/e.~ 
The peptides reproducing the sequelle~s 48-64 and 353-369 of CSK 
were coupled to keyhole limpet hemocyanin with a ¢oaplia8 kit (Pierce 
Chemical Co.). Four rabbits were injected and the sera were moni- 
tored by Western blots of spleen soluble and particulate fractions. All 
sera det~ted a 49 kDa band that could be abolished by preincubation 
of the ~era with the corresponding peptides (300/.tM). 
2.2. Western blots 
Enzyme fractions wer~ subjectt~l to 8% SDS.polyacrylamide gel 
electrophoresis. Proteins were transferred tonitroc.ellulo~e filters in a 
Heeler apparatus at 400 mV for 2 h. The filters were blocked for 
i h at room temi'~rature with 3~ L'ovi~e serum albumin in !0 mM 
Tris-HCI, pH 7.5, containing 0.15 M NaCI. The rabbit antisera wer~ 
used at a dilution of 1:200. lmmunoreaetive proteins were incubated 
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with donkey anti-rabbit lg, biotinylated and detected by incubation 
with streptavidin alkaline phosphatase conjugate. 
Purification of TPK-IIB (and CSK) from spleen soluble and partic- 
ulate fractions was performed essentially as described in [8,9] except 
for the disruption of cells, whiclz was obtained in isotonic medium 
~:ontaining 0.25 M sucrose saccharose, 1 mM EDTA, 2 mM MgCI.~, 
100/aM PMSF, 100 mM Tris-HCl, pH 7.5. 
Tyrosine protein kinase activity was routinely tested on 
poly(Glu~,Tyr ~)as in [8]. 
Phosphorylation of pgptid¢ sabstrates was assayed as previously 
described [9]. 
3. RESULTS 
Antisera were raised against he synthetic peptides 
YKAKNKVGREGIIPANY and TAPEALREKKFS- 
TKSDV reproducing the 48-64 and 353-369 sequences 
of CSK (see section 2). Both antisera recognize recombi- 
nant glutathione-S-transferase-CSK expressed in 
E. coli and p49 from Jurkat cells on Western blots (un= 
published ata), 
As shown in Fig. 1 both AB (48-64) and AB (353- 
369) interact on a Western blot with a 49 kDa eompo= 
neat present in partially purified preparations of TPK- 
IIB obtained by DEAE-Sepharose chromatography of 
both cytosol and extracts of the particulate fraction 
Table ] 
Different peptide substrate ~pecificity of CSK-like kinasc and TPK- 
liB 
Peptid¢ substrate Phosphorylation rate by 
CSK-like TPK-IIB 
DRVYIHPF 100 100 
angiotensin II 
AFLEDYFTSTEPQYQPGEblL 894 587 
(c.see [514-533]) 
AFLED .FFTSTEPQYQPGENL 704 77 
(e-see [514-533]Ph¢ sl~) 
AFLEAFFTSTEPQYQPGENL 258 33 
(e-see [514-533]Ala~nPheS'9) 
EDNEYTA 225 2275 
(c.src [412-418]) 
KDDEYNPA 5 192 
(fgr [408-415]) 
RLMTGDTYTAHAGAK 6 15 
(abl [386-400]) 
DENYYKA 203 218 
(syk [515-521]) 
NIDGDGEVNYEE 220 950 
(CaM loop IV) 
EKEYHAE 12 49 
(EGFR[842-848]) 
The phosphorylation rate is expressed relative to that of angiotensin 
11 (=100%). The concentration of peptides was 250 ~M. CSK-like 
kinas¢ and TPK-IIB were re~olved from each other by heparin-Sepha- 
rose chromatography and collected az indicated in Fi 8. 2. The same 
amounts of enzymes in terms of kinase activity toward 2 mM angio- 
tensin (3 pmol - tnin -~) were used. Peptide nomenclature (between 
brackets) is reminiscent of which sequence of the parent protein they 
reproduce. Tyrosines are in bold type. Underlining denotes those 
residues that have been substituted relative to the parent peptide. 
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Fig. 1. Western blots of crude spleen protein tyrosine kinase fractions 
and purified TPK-IIB with various anti-CSK antisera. TPK-IIB from 
either at spleen cytosol (lanes 1, 3, 5, 7 and 8) or particulate fraction 
(lane 4) was partially purified by DEAE-Sepharose, subjected to $DS- 
PAGE, and immunoreacted with the indicated antisera either as such 
(lanes 1, 4, 5 and 8) or after preincubation of the antisera with the 
corresponding peptides (lanes 3 and 7) (for details ee section 2). Lanes 
2, 6 and 9 refer to purified TPK°IIB after Mono-Q. The amount of 
purified TPK-IIB was more than twice that of the partially purified 
enzyme, as judged from kinase activity. 
from rat spleen (lanes 1, 4 and 5). The signal is specific 
since it is readily abolished if the antisera re preineu- 
bated with excess of the antigen peptides (lanes 3 and 
7). The same 49 kDa band is also recognized by anti- 
CSK ~tntisera (raised against bacterially expressed pro- 
tein) provided by Dr. M. Okada [5] (lane 8). 
On the other hand, highly purified TPK-IIB prepara- 
tions from either cytosol or the particulate fraction are 
not recognized by any of the 3 antibodies used (Fig. 1, 
lanes 2, 6 and 9), thus strongly suggesting that TPK-IIB 
is not itself responsible for the immunoreactivity dis- 
played by partially purified preparations. The dear-cut 
demonstration that indeed CSK and TPK-IIB are dis- 
tinct entities was provided by subjecting the DEAE- 
cellulose fraction exhibiting both tyrosine kinase activ- 
ity and CSK immunoreactivity to heparin-Sepharose 
chromatography and by probing the individual frac- 
tions for their reactivity with AB (48-64). As already 
known [8] TPK-IIB eluted from heparin-Sepharose with 
0.45 M NaCI (see Fig. 2). It is preceded, however, by 
a smaller peak of activity eluted with 0.27 M NaCI. 
While the activity of the small peak coelutes with im- 
munoreactivity against antisera AB [48-64], the main 
peak of TPK-IIB activity is entirely devoid of such a 
property (inset of Fig. 2). 
The two peaks were separately purified by 
phosphocellulose column chromatography and Mono- 
Q FPLC where the immunoreaetive CSK-like protein 
kinase is eluted with 0.22 M NaCI, whereas non-im- 
munoreactive TPK-IIB is less retarded, and elated with 
0.18 M NaCI (data not shown). 
The peptide substrate specificities of these two ki- 
II. In particular CSK and TPK-IIB display an opposite 
preference toward peptides reproducing the two main 
phosphoacceptor sites of pp60~'~% namely Tyr-416 and 
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Fig. 2. Resolution of TPK-I1B and CSK-like activities by heparin- 
Sepharose. Aliqaots of 20 and 40/.d were assayed for protein t.vrosine 
kinase activity and immunoreactivity with anti,era AB(48-64), respec- 
tively. Western blots of individual fraetions, as indicated, are shown 
in the inset. Other experimental condition5 are detailed in section 2. 
Tyr°527. While, in fact, the best substrates for the CSK- 
like enzyme are two peptides (c-src[514-533] and c- 
src[514-533]Phe~9), reproducing the C-terminal site re- 
sponsible tbr down.regulation, TPK-I1B by far prefers 
a heptapeptide substrate (c-src[412--418]) that repro- 
duces the autophosphorylation site of pp60 ...... (Tyr- 
416). The phosphorylation of the C-terminal peptide 
src[514-533] by TPK-IIB is moreover dramatically re- 
duced when Tyr-6 is replaced by Phe, while this substi- 
tution only slightly affects the phosphorylation by the 
CSK-like kinase. This clearly indicates that the phos. 
phorylation of the C-terminal src peptide by TPK-IIB 
occurs at a residue (Tyr-6 in the peptide, equivalent to 
Tyr-519 in pp60 ~'''~) which is not phosphorylated in 
vivo, whilst the tyrosyl residue responsible for down- 
regulation (Tyr-527, equivalent to Tyr-14 in the peptide) 
is the one preferentially affected by the CSK-Iike kinase. 
While the peptide reproducing the C-terrninal segment 
ofc-src is phosphorylated by CSK more readily than all 
the other tyrosyl peptides tested so far, reproducing the 
phospho-acceptor site-~ of a variety of proteins (see 
Table I), its phosphorylation is seriously hampered 
upon replacement of Ala for Asp-5, equivalent to Asp- 
518 of c-src, which is supposed to be essential for the 
phosphorylation f Tyr-527 in rive [10]. As shown in 
Table II such a negative ffect of substitution is ac- 
counted for by a drop in Vm~, whereas the K~ value is 
almost unchanged. 
4. DISCUSSION 
This report provides the clear-cut demonstration that 
the protein tyrosine kinases termed CSK [5] and TPK- 
liB [8], sharing the unique property of lacking auto- 
phosphorylation activity~ are present in rat spleen cy- 
tosol as two definitely distinct enzymes, based on the 
following criteria: (1) immunoreactivity with various 
anti-CSK antisera that do not recognize TPK-IIB; (2) 
different chromatographic behaviour on heparin- 
Sepharose and mono-Q; and (3) opposite specificity to- 
ward src-derived peptides. In particular, while CSK ex- 
hibits its highest activity toward an eicosapeptide r pro- 
ducing the earboxyl terminal segment of pp60~'~% af- 
fecting its tyrosyl residue that corresponds to Tyr-527, 
responsible for down-regulation f pp60~"% TPK-IIB 
by far prefers the heptapeptide EDNEYTA reproduc- 
ing the main autophosphorylation siteof pp60 ~'r~ and 
its relatively modest phosphorylation f the C-terminal 
peptide is mostly accounted for by the tyrosyl residue 
corresponding to Tyr-519, the phosphorylation of 
which in pp60 ~'~~ has never been reported. 
The remarkable specificity of spleen CSK for Tyr-527 
of pp60 ~'~~" is also outlined by the observation that the 
two peptides reproducing this site, either as such or with 
Phe substituted for Tyr-519 are by far preferred over all 
the other peptide substrates tested so far. 
The additional finding that the substitution of Ala for 
the aspartyl residue ~quivalent toAsp-518, e~ential for 
down regulation of c-src, slows down the phosphoryla- 
tion of the C-terminal peptide by CSK corroborates the 
concept hat the substrate specificity of this enzyme 
closely reflects its putative role in phosphorylating and 
downregulating the src related protein tyrosine kinases. 
On the other hand the relatively high K~ values of 
CSK for its best peptide substrates (Table II) would 
indicate that the structural information contained in the 
eicosapeptide src[514--533] are not sufficient o ensure 
Table Ii 
Kinetic constants of src-derived peptides for CSK 
Peptide substrate V,~ K,, Efficiency 
(nmol • min -t . mg -t) (mM) (V~/Km} 
AFLEDYFTSTEPQYQPGENL (src[514--533l) 
AFLED=F=FFTSTEPQYQPGENL (src[514-533]Phe ~) 
AFLEA==FFFTSTEPQYQPGENL (src[514-5331Ala~Phe s~9)
EDNEYTA (~rc[412--418]) 
4.00 0.95 4.21 
2.66 0.97 2.74 
0.92 1.10 0.83 
1.35 2.80 0.48 
CSK was resolved from TPK-IIB by heparin-Sepharose chromatography, as in Fig. 2, and partially purified by phosphocellulose column 
chromatography. Peptide-~ are represented as in Table I. Kinetic constants were determined by regression analysis of double reciprocal plots 
constructed from initial rate measurements. 
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a high affinity binding to CSK, suggesting that higher 
order structural features or perhaps the integrity of the 
whole protein substrate are required in order to opti- 
triize the phosphorylation efficiency by this enzyme. The 
behaviour of TPK.I1B is different also in this respect 
since it displays with the heptapeptide EDNEYTA,  
which is its best substrate, a quite low Km value, in the 
~molar range [9]. Such a high affinity for the peptide 
reproducing a site of  c-src the phosphorylation f which 
correlates with a stimulation of activity suggests that 
TPK- I IB may exert a positive control on c,src.  The 
possibility therefore that TPK-1IB could play a role 
antagonistic to that of  CSK by stimulating instead of 
inhibiting the kinases of  the src  family should be taken 
into account in further studies. 
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